GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Net Income

Shanghai INT Medical Instruments Co (HKSE:01501) Net Income : HK$205.8 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Shanghai INT Medical Instruments Co's Net Income for the six months ended in Dec. 2024 was HK$97.6 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$205.8 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Shanghai INT Medical Instruments Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$0.55.


Shanghai INT Medical Instruments Co Net Income Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Net Income Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income
Get a 7-Day Free Trial Premium Member Only 143.86 175.05 147.09 171.13 204.90

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.31 88.05 83.08 108.23 97.56

Shanghai INT Medical Instruments Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Shanghai INT Medical Instruments Co's Net Income for the fiscal year that ended in Dec. 2024 is calculated as

Net Income(A: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=227.824+-24.914+0+1.991
=204.9

Shanghai INT Medical Instruments Co's Net Income for the quarter that ended in Dec. 2024 is calculated as

Net Income(Q: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=109.581+-12.56+0+0.539
=97.6

Net Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$205.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Shanghai INT Medical Instruments Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Shanghai INT Medical Instruments Co Net Income Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
Executives
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines